Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZCCHC17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM104B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPGS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1S2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFGEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EZR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBXN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRCA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INTS10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC5A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRAME - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GJA9-MYCBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D3P1-DHX40P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on